| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KNTE | Common Stock | Purchase | $1,594,320 | +156,000 | +4.7% | $10.22 | 3,469,330 | 11 Feb 2022 | See Footnotes | F1, F2, F5 |
| transaction | KNTE | Common Stock | Purchase | $206,586 | +20,700 | +0.6% | $9.98 | 3,490,030 | 14 Feb 2022 | See Footnotes | F1, F2, F5 |
| transaction | KNTE | Common Stock | Purchase | $98,900 | +10,000 | +0.29% | $9.89 | 3,500,030 | 14 Feb 2022 | See Footnotes | F1, F2, F5 |
| transaction | KNTE | Common Stock | Purchase | $89,640 | +9,000 | +0.26% | $9.96 | 3,509,030 | 15 Feb 2022 | See Footnotes | F1, F2, F5 |
| holding | KNTE | Common Stock | 84,599 | 11 Feb 2022 | See Footnotes | F3, F5 | |||||
| holding | KNTE | Common Stock | 450,000 | 11 Feb 2022 | See Footnotes | F4, F5 |
| Id | Content |
|---|---|
| F1 | These shares of the Issuer's common stock were purchased in a block order at the price stated in Table I. |
| F2 | These securities are held of record by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("GP VII") is the general partner of OPI VII and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VII. By virtue of such relationship, OrbiMed Advisors and GP VII may be deemed to have voting power and investment power over the securities held by OPI VII and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by OPI VII. |
| F3 | These securities are held of record by OrbiMed Genesis Master Fund, L.P. ("OrbiMed Genesis"). OrbiMed Genesis GP LLC ("Genesis GP") is the general partner of OrbiMed Genesis. OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the managing member of Genesis GP. By virtue of such relationship, OrbiMed Advisors and Genesis GP may be deemed to have voting power and investment power over the securities held by OrbiMed Genesis and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by OrbiMed Genesis. |
| F4 | These securities are held of record by OrbiMed Partners Master Fund Limited ("OPM"). OrbiMed Capital LLC ("OrbiMed Capital") is the investment advisor to OPM. OrbiMed Capital is a relying advisor of OrbiMed Advisors. OrbiMed Advisors and OrbiMed Capital exercise voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPM. |
| F5 | This report on Form 4 is jointly filed by GP VII, OrbiMed Advisors, Genesis GP, and OrbiMed Capital. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. OrbiMed Advisors and GP VII have designated Carl L. Gordon ("Gordon"), a member of OrbiMed Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons, or Gordon, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose |